Long-Term Follow-up on an Intensified Treatment Regimen for Advanced Resectable Head and Neck Squamous Cell Carcinomas

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Investigation

• Publication date

  2001-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1081/CNV-100000147PMID 11296617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship between paclitaxel activity and pathobiology of human solid tumors.

  1998cited by this paper
• Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.

  1998cited by this paper
• Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.

  1998cited by this paper
• Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

  1998cited by this paper
• Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

  1998cited by this paper
• A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results

  1997cited by this paper
• Intensified regimen for advanced head and neck squamous cell carcinomas.

  1997cited by this paper
• Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.

  1997cited by this paper
• Combined-modality therapy for head and neck cancer.

  1997cited by this paper
• Pharmacodynamics of taxol in human head and neck tumors.

  1996cited by this paper
• Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma.

  1996cited by this paper
• Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial.

  1996cited by this paper
• Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.

  1996cited by this paper
• Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer--preliminary report.

  1995cited by this paper
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

  1995cited by this paper
• Radiotherapy, combined with simulataneous chemotherapy with Mitomycin C and bleomycin for inoperable head and neck cancer—preliminary report

  1995cited by this paper
• Combined modality therapy of head and neck cancer.

  1994cited by this paper
• Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials.

  1993cited by this paper
• Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer.

  1993cited by this paper
• Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034.

  1992cited by this paper
• Staging of cancer of the colon and rectum

  1992cited by this paper
• Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

  1992cited by this paper
• Randomised EORTC head and neck cooperative group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma.

  1991cited by this paper
• Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer.

  1990cited by this paper
• A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation. Results from 5 to 10 years.

  1990cited by this paper
• Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer.

  1989cited by this paper
• Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the southwest oncology group

  1988influential reference
• Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group.

  1987cited by this paper
• Effect of cisplatin resistance on cellular radiation response.

  1987cited by this paper
• A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer.

  1987cited by this paper
• Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.

  1987cited by this paper
• Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas--a prospective, randomized study.

  1987cited by this paper
• Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program.

  1986cited by this paper
• The influence of time sequence of cisplatin administration and continuous low dose rate irradiation (CLDRI) on their combined effects on a murine squamous cell carcinoma.

  1985cited by this paper
• Effect of cis-dichlorodiammine platinum II and X rays on mammalian cell survival.

  1981cited by this paper
• Combined bleomycin and radiotherapy in oral cancer.

  1980cited by this paper
• Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study.

  1976cited by this paper

• Systematic review of intraoperative radiation therapy for head and neck cancer

  2022cites this paper
• Intraoperative radiation therapy (IORT) in head and neck cancer

  2016cites this paper
• Dysphagia Secondary to the Effects of Chemotherapy and Radiotherapy

  2013cites this paper
• Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.

  2007cites this paper
• Lokale Chemotherapie oraler und oropharyngealer Plattenepithelkarzinome

  2005cites this paper
• [Local chemotherapy for squamous cell cancer of the oral cavity and oropharynx].

  2005cites this paper
• Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx

  2002cites this paper
• A Phase I Study of SPI-077 (Stealth® Liposomal Cisplatin) Concurrent with Radiation Therapy for Locally Advanced Head and Neck Cancer

  2002cites this paper
• A New Intensified Therapeutic Regimen for Advanced Head and Neck Squamous Cell Carcinomas: Where Does It Fit Among Available Treatment Options?

  2001cites this paper
• Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck

  2000cites this paper